Sepsis Diagnostics Market Analysis: 2022-2027

Sepsis Diagnostics Market Analysis: 2022-2027

Sepsis Diagnostics Market Analysis: 2022-2027
Report code - SRHL115 Published On : Feb,2019 No. of Pages: 212
Sepsis Diagnostics Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth O See more...

“The Sepsis Diagnostics Market is likely to witness an impressive CAGR of 9.0% during the forecast period”.

Market Dynamics

Introduction

Sepsis is a potentially fatal medical condition that occurs when the body's response to an infection damages its tissues. Sepsis diagnostics are used to check for signs of infection or organ damage. Some of these tests are used to identify the germ responsible for the infection that resulted in sepsis.

Market Drivers

Major factors such as the growing number of infectious diseases, the rising number of sepsis incidences, and technology advancements in the field of sepsis diagnostics are expected to drive the growth of the market during the forecast period. The pandemic had a positive impact on the sepsis diagnostics market. COVID-19 increased the demand for sepsis diagnosis due to sepsis cases among COVID-19 patients. 

Segments Analysis

Segmentations

List of Sub-Segments

Dominant and Fastest-Growing Segments

Technology-Type Analysis

Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers

Microbiology is expected to remain the largest technology type segment of the market during the forecast period

 

Testing-Type Analysis

Blood Culture Media and Instruments

Blood culture media is expected to remain the dominant as well as the fastest-growing testing type in the market.

Sepsis-Type Analysis

Pathogen, Bacterial, and Fungal

Bacterial sepsis is expected to hold the largest share of the market during the forecast period.

Testing Site-Type Analysis

Laboratory-Based and Patient Bed Side (POC)

Laboratory testing is expected to remain the larger segment of the market.

Regional Analysis

North America, Europe, Asia-Pacific, and Rest of the World

North America is expected to be the largest market for sepsis diagnostics during the forecast period.

By Technology Type

“Microbiology is expected to remain the largest technology type segment of the market during the forecast period”.

The sepsis diagnostics market is segmented as microbiology, molecular diagnostic, immunoassay, and biomarkers. Microbiology is expected to remain the largest technology type segment of the market during the forecast period owing to the low cost of microbiology techniques and accurate detection of microorganisms for sepsis diagnosis. The molecular segment is expected to be the fastest-growing segment during the forecast period due to high accuracy and less turnaround time. 

By Testing Type

“Blood culture media is expected to remain the dominant as well as the fastest-growing testing type in the market during the forecast period”.

The market is segmented as blood culture media and instruments. Blood culture media is expected to remain the dominant as well as the fastest-growing testing type in the market during the forecast period, due to increasing demand for blood culture media by hospitals and pathology labs. In addition, the convenience and cost-effectiveness of blood culture media are further expected to fuel the growth of the market in the coming years.

By Sepsis Type

“Bacterial sepsis is expected to hold the largest share of the market during the forecast period”.

The market is segmented as pathogen, bacterial, and fungal. Bacterial sepsis is expected to hold the largest share of the market during the forecast period, due to the rise in bacterial sepsis cases, increasing frequency of hospital-transmitted infections, and the increasing number of surgical procedures performed.

By Testing Site Type

“Laboratory testing is expected to remain the larger segment of the market during the forecast period”.

The market is segmented as laboratory-based and patient bed side (POC). Laboratory testing is expected to remain the larger segment of the market during the forecast period. Major factors such as higher accuracy in comparison to POC testing, in-depth analysis, and an increasing number of diagnostic laboratories are driving the growth of the segment.

Regional Analysis

“North America is expected to be the largest market for sepsis diagnostics during the forecast period”.

The market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In terms of regions, North America is expected to be the largest market for sepsis diagnostics during the forecast period. The region has a large number of healthcare infrastructure, and factors such as the adoption of advanced diagnostic solutions, the rising number of infectious diseases, and the presence of key players in the region all contribute to the region's market growth. Asia-Pacific and Europe are also likely to create sizeable growth opportunities in the coming five years.

Key Players

The following are the key players in the Sepsis Diagnostics Market (arranged alphabetically)

  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • BioMérieux SA
  • Bruker Corporation
  • Cerner Corporation
  • Danaher Corporation
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Luminex Corporation
  • Thermo Fisher Scientific, Inc.

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Key questions this report answers

Relevant contents in the report

How big is the sales opportunity?

in-depth Analysis of the Sepsis Diagnostics Market

How lucrative is the future?

The market forecast and trend data and emerging trends

Which regions offer the best sales opportunities?

Global, regional, and country-level historical data and forecasts

Which are the most attractive market segments?

Market segment analysis and Forecast

Which are the top players and their market positioning?

Competitive landscape analysis, Market share analysis

How complex is the business environment?

Porter’s five forces analysis, PEST analysis, Life cycle analysis

What are the factors affecting the market?

Drivers & challenges

Will I get the information on my specific requirement?

10% free customization

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s sepsis diagnostics market realities and future market possibilities for the forecast period. 

The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.

The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. 

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. 

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to three players)
  • SWOT analysis of key players (up to three players)

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research:

Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

The sepsis diagnostics market is estimated to grow at a CAGR of 9.0% by 2027, driven by the increasing cases of infectious diseases, growing awareness regarding sepsis, and increasing investment and R&D in the field of sepsis.

North America is estimated to remain dominant in the sepsis diagnostics market in the foreseen future, due to the presence of major players and well-developed healthcare infrastructure, coupled with the rising aging population and increasing number of patients with sepsis.

Asia-Pacific is estimated to remain the fastest-growing market for sepsis diagnostics in the foreseeable future.

Microbiology is estimated to be the dominant technology type in the market during the forecast period. The low cost of microbiology techniques and the accurate detection of microorganisms for sepsis diagnosis are driving the segment's growth.

Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bruker Corporation, Cerner Corporation, Danaher Corporation, F. Hoffmann-La Roche, GE Healthcare, Luminex Corporation, and Thermo Fisher Scientific, Inc. are the leading players in the sepsis diagnostics market.

The market is studied from 2016-2027.